Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?

Por Ravenstijn, Paulien, Samtani, Mahesh, Russu, Alberto, Hough, David, Gopal, Srihari
Publicado no J Clin Psychopharmacol (2016)

Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling

Por de Lange, Elizabeth C. M., Ravenstijn, Paulien G. M., Groenendaal, Dorien, van Steeg, Tamara J.
Publicado em 2005

Evaluation of blood-brain barrier transport and CNS drug metabolism in diseased and control brain after intravenous L-DOPA in a unilateral rat model of Parkinson's disease

Por Ravenstijn, Paulien GM, Drenth, Henk-Jan, O'Neill, Michael J, Danhof, Meindert, de Lange, Elizabeth CM
Publicado em 2012

Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study

Por Savitz, Adam J., Xu, Haiyan, Gopal, Srihari, Nuamah, Isaac, Ravenstijn, Paulien, Janik, Adam, Schotte, Alain, Hough, David, Fleischhacker, Wolfgang W.
Publicado no Int J Neuropsychopharmacol (2016)

Prospective dose selection and acceleration of paliperidone palmitate 3‐month formulation development using a pharmacometric bridging strategy

Por Samtani, Mahesh N., Nandy, Partha, Ravenstijn, Paulien, Remmerie, Bart, Vermeulen, An, Russu, Alberto, D'hoore, Peter, Baum, Ellen Z., Savitz, Adam, Gopal, Srihari, Hough, David
Publicado no Br J Clin Pharmacol (2016)

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase II...

Por Savitz, Adam J, Xu, Haiyan, Gopal, Srihari, Nuamah, Isaac, Ravenstijn, Paulien, Hough, David, Mathews, Maju, Feng, Yu, Yu, Lu, Takahashi, Masayoshi, Liu, Dennis, Wang, Gang, Yoon, Jin-Sang, Chen, Jiahn-Jyh
Publicado no Neuropsychiatr Dis Treat (2017)